Literature DB >> 1836564

The efficacy of maternal age screening for Down's syndrome in Wessex.

S Youings1, N Gregson, P Jacobs.   

Abstract

The uptake of amniocentesis in Wessex for the period 1986-1988 was 36 per cent (2873 of 8004 births), a proportion that has not altered significantly since 1984. There is a large difference in uptake between women in the lower risk age group, 35-36 years, and those in the higher risk group, 37+ years, and very considerable differences in uptake among different districts. The prenatal detection over the 3-year study period for women aged 35 or more, after correction for spontaneous loss of Down's syndrome fetuses between prenatal detection and birth, is 53 per cent, a figure that must be inflated due to our failure to ascertain all liveborn Down's syndrome patients.

Entities:  

Mesh:

Year:  1991        PMID: 1836564     DOI: 10.1002/pd.1970110703

Source DB:  PubMed          Journal:  Prenat Diagn        ISSN: 0197-3851            Impact factor:   3.050


  3 in total

1.  Strategies for antenatal detection of Down's syndrome.

Authors:  J P Wyllie; R J Madar; M Wright; J Burn; C Wren
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  1997-01       Impact factor: 5.747

2.  The ethics of antenatal screening: lessons from Canute.

Authors:  Timothy M Reynolds
Journal:  Clin Biochem Rev       Date:  2009-11

3.  Periodic health examination, 1996 update: 1. Prenatal screening for and diagnosis of Down syndrome. Canadian Task Force on the Periodic Health Examination.

Authors:  P T Dick
Journal:  CMAJ       Date:  1996-02-15       Impact factor: 8.262

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.